Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

By James B. Meigs, F. B. Hu, N. Rifai, JoAnn E. Manson. Journal of the American Medical Association (JAMA), 2004

669 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/1b451a3aafbb31ff71f9c9645c0a0e3a102ebfe7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. James B. Meigs
2. Peter W. F. Wilson
3. Ralph B. D’Agostino

In Molecular Biology

1. D. Nathan
2. Ramachandran S. Vasan

In Physiology

1. D. Nathan

Citations in the corpus

• Endothelial dysfunction in diabetes mellitus (2007, neutral): “Adjustment for waist circumference instead of BMI or further adjustment for baseline levels of C-reactive protein, fasting insulin, and HbA1c or exclusion of cases diagnosed during the fi rst 4 years of follow-up did not alter these associations (Meigs et al 2004).”
• Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. (2006, background): “In the obese-without MetS phenotype, in particular, measurement of subclinical inflammation, endothelial dysfunction, or adiponectin (13, 43, 47, 48) might reveal less than perfect metabolic health.”